PHASE II STUDY OF NEOADJUVANT VINCRISTINE, IFOSFAMIDE, DOXORUBICIN, AND G-CSF [filgrastim] IN CHILDREN WITH ADVANCED STAGE NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMAS
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin; Ifosfamide; Vincristine
- Indications Sarcoma
- Focus Therapeutic Use
- 25 Jul 2014 Biomarkers information updated
- 16 Sep 2005 New trial record.